Your browser doesn't support javascript.
loading
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.
Meel, Michaël H; Guillén Navarro, Miriam; de Gooijer, Mark C; Metselaar, Dennis S; Waranecki, Piotr; Breur, Marjolein; Lagerweij, Tonny; Wedekind, Laurine E; Koster, Jan; van de Wetering, Marianne D; Schouten-van Meeteren, Netteke; Aronica, Eleonora; van Tellingen, Olaf; Bugiani, Marianna; Phoenix, Timothy N; Kaspers, Gertjan J L; Hulleman, Esther.
Afiliación
  • Meel MH; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Guillén Navarro M; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • de Gooijer MC; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Metselaar DS; Division of Pharmacology/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Waranecki P; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Breur M; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Lagerweij T; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Wedekind LE; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Koster J; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • van de Wetering MD; Department of Neurosurgery, Neuro-oncology Research Group, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Schouten-van Meeteren N; Department of Neurosurgery, Neuro-oncology Research Group, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Aronica E; Department of Oncogenomics, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • van Tellingen O; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Bugiani M; Department of Pediatric Oncology, Academic Medical Center, Emma Children's Hospital, Amsterdam, Netherlands.
  • Phoenix TN; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Kaspers GJL; Department of Pediatric Oncology, Academic Medical Center, Emma Children's Hospital, Amsterdam, Netherlands.
  • Hulleman E; Department of (Neuro) Pathology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Neuro Oncol ; 22(1): 58-69, 2020 01 11.
Article en En | MEDLINE | ID: mdl-31504799
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridonas / Pirimidinonas / Teratoma / Barrera Hematoencefálica / Proteínas Serina-Treonina Quinasas / Tumor Rabdoide / Quinasas de Proteína Quinasa Activadas por Mitógenos / Naftiridinas Límite: Animals / Female / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridonas / Pirimidinonas / Teratoma / Barrera Hematoencefálica / Proteínas Serina-Treonina Quinasas / Tumor Rabdoide / Quinasas de Proteína Quinasa Activadas por Mitógenos / Naftiridinas Límite: Animals / Female / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido